Mint-Imatinib 100 mg – DIN 02492334
Mint-Imatinib is Imatinib Mesylate 100 mg (tablet), sold in Canada. It is used for lymphoid leukemia, myeloid leukemia and dermatofibrosarcoma. It is supplied by Mint Pharmaceuticals Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Imatinib Mesylate 100 mg
- Brand
- Mint-Imatinib
- Strength
- 100 mg
- Used for
- Lymphoid leukemia, myeloid leukemia and dermatofibrosarcoma
- Form
- Tablet
- Manufacturer
- Mint Pharmaceuticals Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02492334
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Imatinib used for?
Imatinib is used for lymphoid leukemia, myeloid leukemia and dermatofibrosarcoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Newly Diagnosed Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML)
Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Ph+ CML in Blast Crisis (BC), Accelerated Phase (AP) or Chronic Phase (CP) After Interferon-alpha (IFN) Therapy
Patients with Philadelphia chromosome positive chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.
Adult Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Pediatric Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy.
Myelodysplastic/Myeloproliferative Diseases (MDS/MPD)
Adult patients with myelodysplastic/myeloproliferative diseases associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements.
Aggressive Systemic Mastocytosis (ASM)
Adult patients with aggressive systemic mastocytosis without the D816V c-Kit mutation or with c-Kit mutational status unknown.
Hypereosinophilic Syndrome (HES) and/or Chronic Eosinophilic Leukemia (CEL)
Adult patients with hypereosinophilic syndrome and/or chronic eosinophilic leukemia who have the FIP1L1-PDGFRα fusion kinase (mutational analysis or fluorescence in situ hybridization [FISH] demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRα fusion kinase negative or unknown.
Dermatofibrosarcoma Protuberans (DFSP)
Adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans.
Kit+ Gastrointestinal Stromal Tumors (GIST)
Patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors.
Adjuvant Treatment of GIST
Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.
From the FDA-approved label on DailyMed (published Oct 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02492334.
- It names Mint-Imatinib, Imatinib Mesylate 100 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Mint-Imatinib by Mint Pharmaceuticals Inc.
In Canada: prescription only.
Ingredients
Active: Imatinib (Imatinib Mesylate)
Other Imatinib pills
-
IMA 100 APO
Imatinib Mesylate 100 mg
Orange, round, 9 mm
Used for lymphoid leukemia and myeloid leukemia
- S 1 Imatinib Mesylate 100 mg Yellow, round, 7 mm Used for lymphoid leukemia and myeloid leukemia
- 51 Imatinib Mesylate 100 mg Brown, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- 472 Imatinib Mesylate 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- 1 scoreline Imatinib 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- M I 100 Imatinib 100 mg Brown, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- H 7 Imatinib Mesylate 100 mg White, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- CE 138 Imatinib Mesylate 100 mg Orange, round, 7 mm Used for lymphoid leukemia and myeloid leukemia